Business
CSL open to new manufacturing options after AstraZeneca production – Sydney Morning Herald
The biotech giant says it can hit the 50 million dose mark by December and is in talks with the government about how else it can help fight the pandemic.
Biotech giant CSL is in talks with the government about its longer-term role in Australias fight against coronavirus, as the company races to complete 50 million doses of the AstraZeneca vaccine by December.
The $123 billion blood plasma giant confirmed over the weekend that it was now producing more than 1 million doses of the vaccine per week, with more than 3.7 million doses released to the public by the end of April. There is a four-week quality control and approvals process that must be completed…
-
Noosa News22 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Noosa News23 hours agoForum responds to urgent homelessness issues in Nambour
-
Business20 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General16 hours agoMigrants raise concerns over Australia’s English tests for visa applicants